Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC38 | AS605240 | 2 | 72 | 1.0 | 2465.5 | 3173.5 | 690.5 | 0.0 | 0.783 | 0.777 | 2.200 | HCC38 AS605240 0 2 72 |
HCC38 | AS605240 | 2 | 72 | 3.2 | 2056.3 | 3173.5 | 690.5 | 0.505 | 0.642 | 0.648 | 2.200 | HCC38 AS605240 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.001 | 3000.0 | 3027.0 | 690.5 | -3.0 | 0.992 | 0.991 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.0032 | 2939.3 | 3027.0 | 690.5 | -2.49 | 0.973 | 0.971 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.01 | 2990.5 | 3027.0 | 690.5 | -2.0 | 0.989 | 0.988 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.032 | 3000.0 | 3027.0 | 690.5 | -1.49 | 0.992 | 0.991 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.1 | 3010.8 | 3027.0 | 690.5 | -1.0 | 0.995 | 0.995 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 0.32 | 2804.0 | 3027.0 | 690.5 | -0.495 | 0.929 | 0.926 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 1.0 | 2812.3 | 3027.0 | 690.5 | 0.0 | 0.932 | 0.929 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD-6482 | 2 | 72 | 3.2 | 2707.3 | 3027.0 | 690.5 | 0.505 | 0.898 | 0.894 | 2.132 | HCC38 AZD6482 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.001 | 2942.8 | 3018.8 | 690.5 | -3.0 | 0.976 | 0.975 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.0032 | 2615.3 | 3018.8 | 690.5 | -2.49 | 0.870 | 0.866 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.01 | 2511.5 | 3018.8 | 690.5 | -2.0 | 0.834 | 0.832 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.032 | 2028.8 | 3018.8 | 690.5 | -1.49 | 0.659 | 0.672 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.1 | 1413.3 | 3018.8 | 690.5 | -1.0 | 0.400 | 0.468 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 0.32 | 1064.5 | 3018.8 | 690.5 | -0.495 | 0.226 | 0.353 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 1.0 | 968.3 | 3018.8 | 690.5 | 0.0 | 0.172 | 0.321 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | AZD8055 | 2 | 72 | 3.2 | 947.0 | 3018.8 | 690.5 | 0.505 | 0.160 | 0.314 | 2.128 | HCC38 AZD8055 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.001 | 2724.5 | 3001.5 | 690.5 | -3.0 | 0.911 | 0.908 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.0032 | 2294.8 | 3001.5 | 690.5 | -2.49 | 0.762 | 0.765 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.01 | 1604.0 | 3001.5 | 690.5 | -2.0 | 0.488 | 0.534 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.032 | 1163.5 | 3001.5 | 690.5 | -1.49 | 0.279 | 0.388 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.1 | 1009.5 | 3001.5 | 690.5 | -1.0 | 0.196 | 0.336 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 0.32 | 916.0 | 3001.5 | 690.5 | -0.495 | 0.143 | 0.305 | 2.120 | HCC38 BEZ235 0 2 72 |
HCC38 | Dactolisib | 2 | 72 | 1.0 | 726.5 | 3001.5 | 690.5 | 0.0 | 0.024 | 0.242 | 2.120 | HCC38 BEZ235 0 2 72 |